Katherine Krajewski
Overview
Explore the profile of Katherine Krajewski including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
21
Citations
414
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Choe J, Kim K, Kim H, Kim D, Kim K, Hong S, et al.
Korean J Radiol
. 2019 Jan;
20(1):5-17.
PMID: 30627018
The diagnosis and management of pancreatic neuroendocrine neoplasms (NENs) have evolved significantly in recent years. There are several diagnostic and therapeutic challenges and controversies regarding the management of these lesions....
2.
McKay R, Bosse D, Gray K, Michaelson M, Krajewski K, Jacene H, et al.
Clin Cancer Res
. 2018 Jun;
24(17):4081-4088.
PMID: 29848570
This study investigates the biologic activity of radium-223 with VEGF-targeted therapy in patients with advanced renal cell carcinoma (aRCC) and bone metastases. Fifteen treatment-naïve patients ( = 15) received pazopanib...
3.
Gosangi B, Davids M, Somarouthu B, Alessandrino F, Giardino A, Ramaiya N, et al.
Cancer Imaging
. 2018 Apr;
18(1):13.
PMID: 29669600
The last 5 years have been marked by profound innovation in the targeted treatment of chronic lymphocytic leukemia (CLL) and indolent lymphomas. Using CLL as a case study, we present...
4.
Richman D, Tirumani S, Hornick J, Fuchs C, Howard S, Krajewski K, et al.
Abdom Radiol (NY)
. 2016 Sep;
42(1):124-140.
PMID: 27645897
Despite advances in molecular biology, imaging, and treatment, gastric neoplasms remain a significant cause of morbidity and mortality; gastric adenocarcinoma is the fifth most common malignancy and third most common...
5.
Albiges L, Fay A, Xie W, Krajewski K, Mcdermott D, Heng D, et al.
Eur J Cancer
. 2015 Sep;
51(17):2580-6.
PMID: 26346135
Background: Monoclonal antibodies that target the programmed death-1 (PD-1)/programmed death-ligand 1(PD-L1) pathway have shown antitumour activity in metastatic renal cell carcinoma (mRCC) and are currently being developed in first-line (in...
6.
Baheti A, Tirumani S, Giardino A, Rosenthal M, Tirumani H, Krajewski K, et al.
AJR Am J Roentgenol
. 2015 Jan;
204(2):W132-40.
PMID: 25615773
OBJECTIVE. Basal cell carcinoma (BCC) is the most common malignancy in the United States. The purpose of this article is to provide a comprehensive description of the clinicopathologic features, diagnostic...
7.
Tapper E, Krajewski K, Lai M, Challies T, Kane R, Afdhal N, et al.
Gastroenterol Rep (Oxf)
. 2014 Jul;
2(4):276-80.
PMID: 25002154
Background And Aims: Non-alcoholic fatty liver disease (NAFLD) is a common, morbid disease with profound implications for the overall health of the patient. We set out to determine the clinical...
8.
Souza F, de Angelo M, ORegan K, Jagannathan J, Jagganathan J, Krajewski K, et al.
Clin Imaging
. 2012 Dec;
37(1):8-17.
PMID: 23206603
Unlabelled: Malignant primary chest wall neoplasms (MCWN) are uncommon. Although benign chest wall neoplasms are most commonly asymptomatic, MCWN typically manifest as painful, fast growing masses. While the imaging features...
9.
Zukotynski K, Lewis A, ORegan K, Jacene H, Sakellis C, Krajewski K, et al.
AJR Am J Roentgenol
. 2012 Jul;
199(2):W163-7.
PMID: 22826417
Objective: PET/CT with (18)F-FDG shows metabolically active disease and is widely used for the diagnosis and follow-up of patients with cancer. Nonmetabolically active renal pathology may be missed without close...
10.
Shah S, Jagannathan J, Krajewski K, ORegan K, George S, Ramaiya N
AJR Am J Roentgenol
. 2012 Jun;
199(1):213-23.
PMID: 22733915
Objective: The purpose of this article is to provide an updated review of uterine sarcomas. The traditionally described neoplasms are reviewed as well as several recently characterized entities in terms...